文献速递角膜与眼表疾病

优化角膜缘干细胞缺乏症的诊断与分类

Refining How We Diagnose and Classify Limbal Stem Cell deficiency.
PubMed 文献 · Am J Ophthalmol · 2026-08-03

本文综述了角膜缘干细胞缺乏症(LSCD)诊断与分期的最相关文献,回顾其临床表现与病理生理,并讨论影响LSC功能与存活的因素。国际LSCD工作组已提出首部关于LSCD定义、分类、诊断、分期和管理的指南;荧光素染色主观性限制精确诊断,需结合多模式眼前节成像与分子检测综合评估眼表环境以精准分期。

要点

  • 国际LSCD工作组已提出首部涵盖定义、分类、诊断、分期和管理的指南。
  • 荧光素染色试验具主观性,限制LSCD的精确诊断与分期。
  • 应整合多模式成像与分子检测综合评估LSC功能及眼表环境。

核心结论

  • LSCD诊断与分类已超越单纯荧光素染色检测角膜表面异常上皮细胞的做法。
  • 通过整合多模式成像与分子检测综合评估LSC功能和眼表环境,可实现LSC功能的精准分期并识别影响LSCD可逆性的因素。
  • 采用标准化多模式诊断框架将提高诊断准确性、指导疾病管理、促进临床研究间比较,并支持新兴细胞类与无细胞再生疗法的开发与评估。

研究设计与样本

  • 本文为综述,回顾了关于LSCD诊断与分期方法的最相关出版物。
  • 文中回顾了LSCD的临床表现与病理生理,并讨论和概述了影响LSC功能与存活的因素。

主要发现

  • 国际LSCD工作组已提出首部关于LSCD定义、分类、诊断、分期和管理的指南。
  • 荧光素染色试验的主观性限制了LSCD的精确诊断与分期。
  • 干眼病、眼表炎症、角膜神经支配、结膜健康、药物毒性和眼睑异常等共病会负面影响角膜上皮细胞和LSC的功能,应纳入LSC功能的初始评估。
  • 眼前节光学相干断层扫描和活体共聚焦显微镜可客观评估上皮表型、细胞形态、基底细胞密度、角膜神经支配及角膜和角膜缘的炎症细胞浸润。
  • 印迹细胞学仍是客观确认结膜化的有价值工具,通过评估上皮表型实现。

临床怎么用

  • 诊断LSCD不应仅依赖荧光素染色,应结合多模式眼前节成像与分子检测综合评估LSC功能与眼表环境。
  • 初始评估LSC功能时应同时评估干眼病、眼表炎症、角膜神经支配、结膜健康、药物毒性和眼睑异常等共病。
  • 可采用眼前节OCT与活体共聚焦显微镜客观评估上皮表型、细胞形态、基底细胞密度、角膜神经支配和炎症细胞浸润。
  • 印迹细胞学可用于客观确认结膜化。
  • 采用标准化多模式诊断框架以指导疾病管理并促进临床研究间比较。

局限性

  • 荧光素染色试验具有主观性,限制LSCD的精确诊断与分期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: Refining how we diagnose and classify limbal stem cell deficiency. CLINICAL RELEVANCE: With the development of multimodal anterior segment imaging modalities and molecular diagnostic tests for the diagnosis and staging of limbal stem cell deficiency (LSCD), and better understanding of LSCD presentation and pathophysiology, a comprehensive step-by-step algorithm is established to more precisely evaluate the ocular surface environment and stage the disease. METHODS: This is a review of the most relevant publications on the method of diagnosing and staging LSCD. Clinical presentation and pathophysiology of LSCD were reviewed. Factors that impact LSC function and survival were discussed and outlined. RESULTS: The International LSCD Working Group has put forth the first guidelines on the definition, classification, diagnosis, staging, and management of LSCD. Precise diagnosis and staging of LSCD is limited by subjective nature of the fluorescein staining test. As other comorbidities negatively impact the function of both corneal epithelial cells and LSCs, assessment of these comorbidities such as dry eye disease, ocular surface inflammation, corneal innervation, conjunctival health, medication toxicity, and eyelid abnormalities should be included in the initial evaluation of LSC function. Advances in anterior segment imaging, including anterior segment optical coherence tomography and in vivo confocal microscopy allow objective evaluation of epithelial phenotype, cellular morphology, basal cell density, corneal innervation, and inflammatory cell infiltration in both the cornea and limbus. The knowledge of ocular surface microstructure provides important information regarding the corneal and limbal epithelial cell function, remaining LSC reserve, and factors associated with LSCD improvement after all comorbidities are treated. Impression cytology remains a valuable tool for objectively confirming conjunctivalization through assessment of epithelial phenotype. CONCLUSION: LSCD diagnosis and classification have advanced beyond the simple fluorescein staining test for the detection of abnormal epithelial cells on the corneal surface. A comprehensive assessment of the LSC function and the ocular surface environment by integrating multimodal imaging and molecular testing enables precise staging of LSC function and identification of factors that influence LSCD reversibility. Adoption of a standardized multimodal diagnostic framework will improve diagnostic accuracy, guide the management of the disease, facilitate comparisons across clinical studies, and support the development and evaluation of emerging cell-based and cell-free regenerative therapies for LSCD.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bonnet C, Slomovic A, Kruse F, et al. Refining How We Diagnose and Classify Limbal Stem Cell deficiency. Am J Ophthalmol. 2026. PMID: 42546866. doi:10.1016/j.ajo.2026.07.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。